Innate Pharma highlights durable responses to lacutamab in Sezary syndrome and mycosis fungoides
Summary by Innate-pharma.com
1 Articles
1 Articles
Innate Pharma highlights durable responses to lacutamab in Sezary syndrome and mycosis fungoides
Innate Pharma highlights durable responses to lacutamab in Sezary syndrome and mycosis fungoides Fri, 05/23/2025 - 07:00 Press Release in English 230.44 KB Communiqué de presse en français 188.74 KB mathilde Thu, 05/22/2025
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium